Cargando…

Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy

Membranous nephropathy (MN) is an autoimmune disease characterized by the deposition of immunoglobulin G (IgG) and complementary components in the epithelium of the glomerular capillary wall. Macrophage migration inhibitory factor (MIF) is an inflammatory mediator released by macrophages. MIF plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Na, Li, Peng-Lei, Wu, Kai-Li, Lv, Tie-Gang, Yu, Wen-Lu, Hao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633699/
https://www.ncbi.nlm.nih.gov/pubmed/36329091
http://dx.doi.org/10.1038/s41598-022-23440-1
_version_ 1784824295995736064
author Ding, Na
Li, Peng-Lei
Wu, Kai-Li
Lv, Tie-Gang
Yu, Wen-Lu
Hao, Jian
author_facet Ding, Na
Li, Peng-Lei
Wu, Kai-Li
Lv, Tie-Gang
Yu, Wen-Lu
Hao, Jian
author_sort Ding, Na
collection PubMed
description Membranous nephropathy (MN) is an autoimmune disease characterized by the deposition of immunoglobulin G (IgG) and complementary components in the epithelium of the glomerular capillary wall. Macrophage migration inhibitory factor (MIF) is an inflammatory mediator released by macrophages. MIF plays a key regulatory function in the pathogenesis of immune-mediated glomerulonephritis. This study aimed to investigate whether MIF level could be associated with the activity of MN. Plasma and urine samples from 57 MN patients and 20 healthy controls were collected. The MIF levels in plasma and urine were determined by an enzyme-linked immunosorbent assay (ELISA) kit. The expression of MIF in the renal specimens from 5 MN patients was detected by immunohistochemistry (IHC). The associations of the plasma and urinary levels of MIF and glomerular MIF expression with clinical and pathological characteristics were analyzed. It was revealed that with the increase of MIF levels in plasma and urine, the severity of renal pathological injury in MN patients gradually increased. Correlation analysis showed that the MIF levels in plasma were positively correlated with the platelet (PLT) count (r = 0.302, P = 0.022), and inversely correlated with the prothrombin time (PT) (r =  − 0.292, P = 0.028) in MN patients. The MIF levels in plasma were positively correlated with the C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) (r = 0.651, P < 0.0001; r = 0.669, P < 0.0001) in MN patients. The urinary levels of MIF were positively correlated with ESR (r = 0.562, P < 0.0001). IHC suggested that MIF was expressed in glomerular basement membrane and tubulointerstitial areas. MIF levels in plasma and urine could reflect the severity of MN, and MIF levels in plasma and urine could be associated with venous thrombosis and infectious complications in MN patients. The glomerular MIF expression could be used to indicate the activity of MN.
format Online
Article
Text
id pubmed-9633699
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96336992022-11-05 Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy Ding, Na Li, Peng-Lei Wu, Kai-Li Lv, Tie-Gang Yu, Wen-Lu Hao, Jian Sci Rep Article Membranous nephropathy (MN) is an autoimmune disease characterized by the deposition of immunoglobulin G (IgG) and complementary components in the epithelium of the glomerular capillary wall. Macrophage migration inhibitory factor (MIF) is an inflammatory mediator released by macrophages. MIF plays a key regulatory function in the pathogenesis of immune-mediated glomerulonephritis. This study aimed to investigate whether MIF level could be associated with the activity of MN. Plasma and urine samples from 57 MN patients and 20 healthy controls were collected. The MIF levels in plasma and urine were determined by an enzyme-linked immunosorbent assay (ELISA) kit. The expression of MIF in the renal specimens from 5 MN patients was detected by immunohistochemistry (IHC). The associations of the plasma and urinary levels of MIF and glomerular MIF expression with clinical and pathological characteristics were analyzed. It was revealed that with the increase of MIF levels in plasma and urine, the severity of renal pathological injury in MN patients gradually increased. Correlation analysis showed that the MIF levels in plasma were positively correlated with the platelet (PLT) count (r = 0.302, P = 0.022), and inversely correlated with the prothrombin time (PT) (r =  − 0.292, P = 0.028) in MN patients. The MIF levels in plasma were positively correlated with the C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) (r = 0.651, P < 0.0001; r = 0.669, P < 0.0001) in MN patients. The urinary levels of MIF were positively correlated with ESR (r = 0.562, P < 0.0001). IHC suggested that MIF was expressed in glomerular basement membrane and tubulointerstitial areas. MIF levels in plasma and urine could reflect the severity of MN, and MIF levels in plasma and urine could be associated with venous thrombosis and infectious complications in MN patients. The glomerular MIF expression could be used to indicate the activity of MN. Nature Publishing Group UK 2022-11-03 /pmc/articles/PMC9633699/ /pubmed/36329091 http://dx.doi.org/10.1038/s41598-022-23440-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ding, Na
Li, Peng-Lei
Wu, Kai-Li
Lv, Tie-Gang
Yu, Wen-Lu
Hao, Jian
Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title_full Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title_fullStr Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title_full_unstemmed Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title_short Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
title_sort macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633699/
https://www.ncbi.nlm.nih.gov/pubmed/36329091
http://dx.doi.org/10.1038/s41598-022-23440-1
work_keys_str_mv AT dingna macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy
AT lipenglei macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy
AT wukaili macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy
AT lvtiegang macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy
AT yuwenlu macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy
AT haojian macrophagemigrationinhibitoryfactorlevelsareassociatedwithdiseaseactivityandpossiblecomplicationsinmembranousnephropathy